US gives go ahead to Alzheimer's drug

The US food and drug administration has cleared Eisai's Alzheimer's drug, Aricept, to treat severe dementia in patients with the degenerative brain disease.

    Ronald Reagan suffered from Alzheimer's

    The drug, which is also marketed by Pfizer, is already approved to treat mild to moderate dementia in patients of Alzheimer's, which affects roughly 4.5 million mostly older Americans.

    There is no cure for the condition, typified by memory loss and other cognitive impairment that can quickly worsen.

    Alzheimer's is the most common form of dementia.

    Eisai, based in Japan, earlier this month cited growing US sales of the drug thanks to Medicare's new prescription drug benefit for the elderly and disabled.

    It has forecast total Aricept sales at $1.9 billion, for the fiscal year through March 2007. Some analysts have said that estimate is conservative, but company officials have declined to comment.

    SOURCE: Reuters


    YOU MIGHT ALSO LIKE

    Musta'ribeen, Israel's agents who pose as Palestinians

    Who are the Israeli agents posing as Palestinians?

    Musta'ribeen are an elite Israeli undercover unit that disguises themselves as Arabs or Palestinians.

    Stories from the sex trade

    Stories from the sex trade

    Dutch sex workers, pimps and johns share their stories.

     How Britain Destroyed the Palestinian Homeland

    How Britain Destroyed the Palestinian Homeland

    100 years since Balfour's "promise", Palestinians insist that their rights in Palestine cannot be dismissed.